INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

When teenagers or adults do get hand, foot and mouth disease, symptoms are usually mild or may not appear at all. Some adults ...

A hidden atrial dysfunction may raise stroke risk in people with transthyretin amyloid cardiomyopathy (ATTR-CM); however, a noninvasive assessment tool may help identify those at increased risk, ...

A new doctoral thesis recently published by Giorgi Beridze at Karolinska Institutet sheds light on the relationship between ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, ...

Discover a study exploring how high serum TSLP influences adult asthma and implications for targeted treatment.

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...

Significant increases in risk were linked to menopausal hormone therapy for all autoimmune diseases except Graves disease and hepatitis.

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with ...

The global population is ageing and this demographic shift has profound effects on haemostasis, notably a progressive tilt ...